PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Physiology and Pathophysiology, Medical University of Białystok, 15-222 Białystok, Poland.\', \'Department of Clinical Pharmacy, Medical University of Białystok, 15-222 Białystok, Poland.\', \'Department of Pharmacology and Toxicology, University of Bonn, 53127 Bonn, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 198610.3390/ijms22041986
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 33671463
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33671463>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33671463>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all